ZIM Integrated Shipping Stock: Better Value Than Investors Realize (NYSE:ZIM)
By Press Room
1 Mins read
This article was written by Follow A financial researcher and avid investor with a keen eye for innovation and disruption, as well…
SCHG ETF: The Gentle Giant May Have Upside Potential Amid Valuation Decline (SCHG)
By Press Room
1 Mins read
This article was written by Follow Financial Serenity is a financial analysis and quantitative research column with a particular focus on the…
AES Makes A Lot Of Sense As Both A Value And Dividend Growth Stock (NYSE:AES)
By Press Room
1 Mins read
This article was written by Follow I’m Jason Ditz and I have 20 years of experience in foreign policy research. My work…
This article was written by Follow I have been an investor for several decades enduring the 87 crash, 2000 crash, and 08…
Nelnet: Consistent Value Creation Not Being Rewarded By The Market (NYSE:NNI)
By Press Room
1 Mins read
This article was written by Follow An individual investor primarily focused on undercovered companies, with more than 50 companies on my watchlist….
TMFG ETF: High-Conviction Global Strategy With A High Fee And Mixed Results (BATS:TMFG)
By Press Room
1 Mins read
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced…
This article was written by Follow Philipp is a seasoned value investor with nearly 20 years of experience in the field. He…
Imperial Brands: Resilient Market Performance And A Strong Cash Flow Yield (OTCMKTS:IMBBY)
By Press Room
1 Mins read
This article was written by Follow I have more than five years experience in the financial industry. I focus mostly in the…
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q4 2024 Results Conference Call March 11, 2025 5:00 PM ET Company Participants Nate Brower – General…
Oncolytics Biotech Stock: Continuing To Justify The Negativity (NASDAQ:ONCY)
By Press Room
1 Mins read
This article was written by Follow I have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech…